Christoph Jacoby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christoph Jacoby has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Jürgen Schrader
Institut für Molekulare Kardiologie Heinrich‐Heine‐Universität Düsseldorf Düsseldorf Germany
2 shared publicationsUlrich Flögel
Institut für Molekulare Kardiologie Heinrich‐Heine‐Universität Düsseldorf Düsseldorf Germany
2 shared publications- Ulrich Flögel
Heinrich Heine University Düsseldorf
2 shared publications Alma Zernecke
Department of Molecular Cardiovascular Research, Rheinisch‐Westfälische Technische Hochschule Aachen, Aachen, Germany
1 shared publication- Andreas Beck
Department of Computer Sciences, University of Düsseldorf, Düsseldorf, Germany
1 shared publication - Andreas Hippe
Department of Dermatology, University Hospital Duesseldorf, 40225, Duesseldorf, Germany
1 shared publication
Latest Publications
- Open Access
- 2 December 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 1-11
Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice
Recent studies have suggested that adenosine generated by ecto-5′-nucleotidase (CD73) in the tumor microenvironment plays a major role in promoting tumor growth by suppressing the immune response and stimulating angiogenesis via A2A and A2B receptors. However, adenosine has also been reported to inhibit tumor growth acting via A1 and A3 receptors. Therefore the aim of this study was to clarify the role of host CD73, which catalyzes the extracellular hydrolysis of AMP to adenosine, on tumor growth and metastasis of B16-F10 melanoma cells. CD73 and alkaline phosphatase (AP) activity of B16-F10 melanoma cells were measured by HPLC. Tumor cells were injected either subcutaneously or intradermally in WT and CD73−/− mice and tumor growth was monitored by MRI at 9.4 T. Immune cell subpopulations within tumors were assessed by FACS after enzymatic digestion. An endothelium specific CD73−/− was created using Tie2-Cre+ mice and CD73flox/flox (loxP) mice. Chimeric mice lacking CD73−/− on hematopoietic cells was generated by bone marrow transplantation. Lung metastatic spread was measured after intravenous B16-F10 application. B16-F10 cells showed very little CD73 and negligible AP activity. Neither complete loss of host CD73 nor specific knockout of CD73 on endothelial cells or hematopoietic cells affected tumor growth after subcutaneous or intradermal tumor cell application. Only peritumoral edema formation was significantly attenuated in global CD73−/− mice in the intradermal model. Immune cell composition revealed no differences in the different transgenic mice models. Also lung metastasis after intravenous B16-F10 injection was not altered in CD73−/− mice. CD73 expression on host cells, particularly on endothelial and hematopoietic cells, does not modulate tumor growth and metastatic spread of B16-F10 melanoma cells most likely because of insufficient adenosine formation by the tumor itself.
- 2 December 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 1-11
Open AccessGrowth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice
Recent studies have suggested that adenosine generated by ecto-5′-nucleotidase (CD73) in the tumor microenvironment plays a major role in promoting tumor growth by suppressing the immune response and stimulating angiogenesis via A2A and A2B receptors. However, adenosine has also been reported to inhibit tumor growth acting via A1 and A3 receptors. Therefore the aim of this study was to clarify the role of host CD73, which catalyzes the extracellular hydrolysis of AMP to adenosine, on tumor growth and metastasis of B16-F10 melanoma cells. CD73 and alkaline phosphatase (AP) activity of B16-F10 melanoma cells were measured by HPLC. Tumor cells were injected either subcutaneously or intradermally in WT and CD73−/− mice and tumor growth was monitored by MRI at 9.4 T. Immune cell subpopulations within tumors were assessed by FACS after enzymatic digestion. An endothelium specific CD73−/− was created using Tie2-Cre+ mice and CD73flox/flox (loxP) mice. Chimeric mice lacking CD73−/− on hematopoietic cells was generated by bone marrow transplantation. Lung metastatic spread was measured after intravenous B16-F10 application. B16-F10 cells showed very little CD73 and negligible AP activity. Neither complete loss of host CD73 nor specific knockout of CD73 on endothelial cells or hematopoietic cells affected tumor growth after subcutaneous or intradermal tumor cell application. Only peritumoral edema formation was significantly attenuated in global CD73−/− mice in the intradermal model. Immune cell composition revealed no differences in the different transgenic mice models. Also lung metastasis after intravenous B16-F10 injection was not altered in CD73−/− mice. CD73 expression on host cells, particularly on endothelial and hematopoietic cells, does not modulate tumor growth and metastatic spread of B16-F10 melanoma cells most likely because of insufficient adenosine formation by the tumor itself.
- 19 December 2013
- Published by Wiley in NMR in Biomedicine
- Vol. 27 (3) , 261-271
Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity
Inflammatory processes can reliably be assessed by 19F MRI using perfluorocarbons (PFCs), which is primarily based on the efficient uptake of emulsified PFCs by circulating cells of the monocyte–macrophage system and subsequent infiltration of the 19F‐labeled cells into affected tissue. An ideal candidate for the sensitive detection of fluorine‐loaded cells is the biochemically inert perfluoro‐15‐crown‐5 ether (PFCE), as it contains 20 magnetically equivalent 19F atoms. However, the biological half‐life of PFCE in the liver and spleen is extremely long, and so this substance is not suitable for future clinical applications. In the present study, we investigated alternative, nontoxic PFCs with predicted short biological half‐lives and high fluorine content: perfluorooctyl bromide (PFOB), perfluorodecalin (PFD) and trans‐bis‐perfluorobutyl ethylene (F‐44E). Despite the complex spectra of these compounds, we obtained artifact‐free images using sine‐squared acquisition‐weighted three‐dimensional chemical shift imaging and dedicated reconstruction accomplished with in‐house‐developed software. The signal‐to‐noise ratio of the images was maximized using a Nutall window with only moderate localization error. Using this approach, the retention times of the different PFCs in murine liver and spleen were determined at 9.4 T. The biological half‐lives were estimated to be 9 days (PFD), 12 days (PFOB) and 28 days (F‐44E), compared with more than 250 days for PFCE. In vivo sensitivity for inflammation imaging was assessed using an ear clip injury model. The alternative PFCs PFOB and F‐44E provided 37% and 43%, respectively, of the PFCE intensities, whereas PFD did not show any signal in the ear model. Thus, for in vivo monitoring of inflammatory processes, PFOB emerges as the most promising candidate for possible future translation of 19F MR inflammation imaging to human applications. Copyright © 2013 John Wiley & Sons, Ltd.
- 19 December 2013
- Published by Wiley in NMR in Biomedicine
- Vol. 27 (3) , 261-271
Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity
Inflammatory processes can reliably be assessed by 19F MRI using perfluorocarbons (PFCs), which is primarily based on the efficient uptake of emulsified PFCs by circulating cells of the monocyte–macrophage system and subsequent infiltration of the 19F‐labeled cells into affected tissue. An ideal candidate for the sensitive detection of fluorine‐loaded cells is the biochemically inert perfluoro‐15‐crown‐5 ether (PFCE), as it contains 20 magnetically equivalent 19F atoms. However, the biological half‐life of PFCE in the liver and spleen is extremely long, and so this substance is not suitable for future clinical applications. In the present study, we investigated alternative, nontoxic PFCs with predicted short biological half‐lives and high fluorine content: perfluorooctyl bromide (PFOB), perfluorodecalin (PFD) and trans‐bis‐perfluorobutyl ethylene (F‐44E). Despite the complex spectra of these compounds, we obtained artifact‐free images using sine‐squared acquisition‐weighted three‐dimensional chemical shift imaging and dedicated reconstruction accomplished with in‐house‐developed software. The signal‐to‐noise ratio of the images was maximized using a Nutall window with only moderate localization error. Using this approach, the retention times of the different PFCs in murine liver and spleen were determined at 9.4 T. The biological half‐lives were estimated to be 9 days (PFD), 12 days (PFOB) and 28 days (F‐44E), compared with more than 250 days for PFCE. In vivo sensitivity for inflammation imaging was assessed using an ear clip injury model. The alternative PFCs PFOB and F‐44E provided 37% and 43%, respectively, of the PFCE intensities, whereas PFD did not show any signal in the ear model. Thus, for in vivo monitoring of inflammatory processes, PFOB emerges as the most promising candidate for possible future translation of 19F MR inflammation imaging to human applications. Copyright © 2013 John Wiley & Sons, Ltd.
- 1 August 2011
- Published by Springer Nature
- Vol. 771, 439-456
MR for the Investigation of Murine Vasculature
The investigation of alterations in vessel morphology of transgenic mouse models generally requires time-consuming and laborious planimetry of histological sections. This postmortem analysis is per se restricted to endpoint studies and, furthermore, may reflect the situation in vivo to a limited degree only. For the repetitive and noninvasive monitoring of dynamic changes in the murine vasculature, several protocols for high-resolution 3D MR angiography (MRA) at a vertical 9.4 T system are described. These protocols are based on flow-compensated 3D gradient echo sequences with application-dependent spatial resolution, resulting in voxel sizes between 1 and 13 nL. To ensure constant physiological conditions, particular attention is paid to minimize the acquisition time. All measurements are carried out without a contrast agent to avoid temporal inconstancy of the contrast-to-noise-ratio (CNR) as well as toxic side effects. Moreover, metabolic alterations as a consequence of disturbed vascularization and blood supply are monitored by 31P MR spectroscopy.
- 1 August 2011
- Published by Springer Nature
- Vol. 771, 439-456
MR for the Investigation of Murine Vasculature
The investigation of alterations in vessel morphology of transgenic mouse models generally requires time-consuming and laborious planimetry of histological sections. This postmortem analysis is per se restricted to endpoint studies and, furthermore, may reflect the situation in vivo to a limited degree only. For the repetitive and noninvasive monitoring of dynamic changes in the murine vasculature, several protocols for high-resolution 3D MR angiography (MRA) at a vertical 9.4 T system are described. These protocols are based on flow-compensated 3D gradient echo sequences with application-dependent spatial resolution, resulting in voxel sizes between 1 and 13 nL. To ensure constant physiological conditions, particular attention is paid to minimize the acquisition time. All measurements are carried out without a contrast agent to avoid temporal inconstancy of the contrast-to-noise-ratio (CNR) as well as toxic side effects. Moreover, metabolic alterations as a consequence of disturbed vascularization and blood supply are monitored by 31P MR spectroscopy.
- Open Access
- 5 September 2008
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 28 (3) , 637-645
Dynamic changes in murine vessel geometry assessed by high‐resolution magnetic resonance angiography: A 9.4T study
Purpose: To establish high‐resolution magnetic resonance angiography (MRA) protocols to monitor and quantify dynamic changes of vascular remodeling in pathologic mouse models.Materials and Methods: Time‐of‐flight (TOF) MRA of murine vessels was performed at 9.4T to monitor temporal alterations in the vessel structure in two frequently used injury models (wire denudation of carotid artery and femoral artery occlusion). Quantification of vessel morphology was performed with the use of in‐house‐developed software and validated by estimation of inter‐ and intraobserver variabilities and reproducibility, and by correlation with histological data.Results: MRA‐based volume determination exhibited low intra‐ and interobserver variabilities and high reproducibility. Furthermore, good correlations with histological data were found four weeks after injury (R2 = 0.970). Two high‐resolution image series are presented to demonstrate the applicability of the technique: 1) the time course of a vessel stenosis that reopens by thrombus recanalization, and 2) the continuous restoration of blood flow by collateral vessel formation during arteriogenesis after induction of hindlimb ischemia.Conclusion: We describe high‐resolution MRA imaging protocols that are suitable for sensitively measuring the extent and time course of changes in vessel morphology in mice in a repetitive manner without any contrast agent. This methodology provides a reliable tool for noninvasive monitoring of vascular lesion development or neovascularization in transgenic mice. J. Magn. Reson. Imaging 2008;28:637–645.
- 5 September 2008
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 28 (3) , 637-645
Open AccessDynamic changes in murine vessel geometry assessed by high‐resolution magnetic resonance angiography: A 9.4T study
Purpose: To establish high‐resolution magnetic resonance angiography (MRA) protocols to monitor and quantify dynamic changes of vascular remodeling in pathologic mouse models.Materials and Methods: Time‐of‐flight (TOF) MRA of murine vessels was performed at 9.4T to monitor temporal alterations in the vessel structure in two frequently used injury models (wire denudation of carotid artery and femoral artery occlusion). Quantification of vessel morphology was performed with the use of in‐house‐developed software and validated by estimation of inter‐ and intraobserver variabilities and reproducibility, and by correlation with histological data.Results: MRA‐based volume determination exhibited low intra‐ and interobserver variabilities and high reproducibility. Furthermore, good correlations with histological data were found four weeks after injury (R2 = 0.970). Two high‐resolution image series are presented to demonstrate the applicability of the technique: 1) the time course of a vessel stenosis that reopens by thrombus recanalization, and 2) the continuous restoration of blood flow by collateral vessel formation during arteriogenesis after induction of hindlimb ischemia.Conclusion: We describe high‐resolution MRA imaging protocols that are suitable for sensitively measuring the extent and time course of changes in vessel morphology in mice in a repetitive manner without any contrast agent. This methodology provides a reliable tool for noninvasive monitoring of vascular lesion development or neovascularization in transgenic mice. J. Magn. Reson. Imaging 2008;28:637–645.